Samsung Biologics Revolutionizes Bioprocess Manufacturing Intelligence by Integrating Digital Twin and AI for Proactive Decision-Making

June 28, 2026

Samsung Biologics South Korea

Overview

Samsung Biologics is revolutionizing manufacturing intelligence by advancing a digital bioprocess framework integrating multivariate data analysis (MVDA), predictive modeling, and explainable AI. This framework enhances process understanding and supports more informed, proactive decision-making through real-time monitoring, predictive analytics, and digital twin strategies. This will lead to exponential improvements in efficiency, quality, and robustness in biopharmaceutical manufacturing, significantly accelerating time-to-market for products.

In Depth

Key Findings

Samsung Biologics is successfully driving the transition from process monitoring to manufacturing intelligence in biopharmaceutical production by establishing a comprehensive digital bioprocess framework that integrates multivariate data analysis (MVDA), predictive modeling, and explainable AI (XAI). This advanced approach enables real-time process surveillance, detailed predictive analytics, and high-fidelity digital twin strategies, deepening process understanding and supporting faster, more effective decision-making.

Technical / Clinical Details

Leveraging Multivariate Data Analysis (MVDA): MVDA provides the ability to simultaneously analyze numerous process parameters, including bioreactor operational data, media composition, and cell metabolites. This reveals complex interrelationships within the process, identifying potential issues and opportunities for efficiency improvement.
Predictive Modeling and Explainable AI (XAI): By combining accumulated data with machine learning algorithms, future process behavior and product quality are predicted with high accuracy. XAI, in particular, presents the rationale behind predictions in a human-understandable format, helping decision-makers trust and quickly act on AI suggestions. This is crucial for early detection of process anomalies and corrective actions.
Real-time Monitoring and Control: The integrated digital framework continuously monitors Critical Process Parameters (CPPs) by collecting and analyzing data from in-line sensors in real-time. This promptly detects process deviations and maintains optimal operating conditions through automated or semi-automated adjustments.
Digital Twin Strategy: A ‘digital twin’ is constructed as a virtual replica of the physical biomanufacturing process in the digital space. This digital twin can be used for various scenario simulations, process optimization, and operator training, allowing for the validation of efficient improvement strategies while minimizing risks in the physical process.
Enhanced Quality and Efficiency: The integration of these digital technologies improves product quality consistency and reduces batch-to-batch variability. It also contributes to reduced manufacturing costs and accelerated time-to-market through process streamlining and reduced downtime.

Background & Context

Biopharmaceutical manufacturing has always faced challenges in maintaining quality and efficiency due to complex processes involving numerous variables. The concepts of Industry 4.0 and digital transformation have swept through the biomanufacturing sector, prompting a shift towards smarter, more autonomous manufacturing systems. Regulatory bodies are also encouraging the adoption of Advanced Manufacturing Technologies, making digitalization an essential component for enhancing quality control and compliance.Strategic Significance & Outlook

Samsung Biologics’ digital bioprocess framework establishes a model for next-generation biomanufacturing. This approach enhances process transparency and predictability, enabling continuous improvement. In the future, this integrated platform is expected to be applied to the manufacturing of more complex cell and gene therapy products, accelerating innovation across the entire value chain from drug development to patient supply. This will enable the faster and more cost-effective provision of high-quality biopharmaceuticals worldwide.

Source: https://samsungbiologics.com/media/science-technology/from-process-monitoring-to-manufacturing-intelligence

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.